Ms. Hassan (for herself and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions, Reported by Mr. Cassidy, with an amendment
To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Medication Affordability and Patent Integrity Act. S. 2658. 119th
Cong., 2nd
sess., Reported in Senate July 28, 2026. https://www.govinfo.gov/app/details/BILLS-119s2658rs.
APA
Congress, Senate (2026, July 28). Medication Affordability and Patent Integrity Act (S. 2658 (RS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s2658rs.
MLA
United States, Congress, Senate. Medication Affordability and Patent Integrity Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s2658rs. 119th Congress, S. 2658, Reported in Senate 28 Jul. 2026.
Bluebook
S.2658 - 119th Congress (2025-2026): Medication Affordability and Patent Integrity Act, S.2658, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119s2658rs.
